Synthetic Biologics and Intrexon have commenced development of a monoclonal antibody (mAb) therapy, SYN-005, to treat pertussis, commonly known as whooping cough. To manage the rising number of pertussis cases, Synthetic Biologics intends ...
Tags: Synthetic Biologics, monoclonal antibody therapy, whooping cough